7,570.10

+28.70

+0.38%

51,776.09

-207.89

-0.40%

25,383.96

+219.60

+0.87%

2,817.90

+12.03

+0.43%

4.9520

+0.0580

+1.19%

21.01

-0.14

-0.66%

3,931.00

-38.60

-0.97%

77,626.31

+986.56

+1.29%

Crude Oil Dec 26

96.65

+0.19

+0.20%

US Private Equity

10,836.30

-14.33

-0.13%

OTC Markets OTCPK - Delayed Quote USD

Sino Biopharmaceutical Limited (SBMFF)

0.6509 -0.0141 (-2.12%)

As of October 30 at 4:00:00 PM EDT. Market Open.

Sino Biopharmaceutical (SEHK:1177) Could Be 71% Below Fair Value Following Phase III Enrollment Update

Simply Wall St. 5d ago

1177.HK
Sino Biopharmaceutical (SEHK:1177) Stock Looks Expensive On Its Current Earnings

Simply Wall St. 14d ago

1177.HK
Transcenta Therapeutics Announces Appointment of Ms. Jennie Ma as Chief Financial Officer

PR Newswire 15d ago

1177.HK

6628.HK
Sino Biopharmaceutical Limited Unveils New Global Brand, SBP Group, to Accelerate International Expansion

PR Newswire 2mo ago

1177.HK
Sino Biopharmaceutical Limited Unveils New Global Brand, SBP Group, to Accelerate International Expansion

CNW Group 2mo ago

1177.HK
Sino Biopharmaceutical Limited Unveils New Global Brand, SBP Group, to Accelerate International Expansion

PR Newswire 2mo ago

1177.HK

Mobilize your Website

View Site in Mobile | Classic

Share by: